If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Omar Ali El-Agnaf is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Synucleins Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences
Amyloid Medicine & Life Sciences
alpha-Synuclein Medicine & Life Sciences
Alzheimer Disease Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Neurodegenerative Diseases Medicine & Life Sciences
Peptides Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration

Durante, V., de Iure, A., Loffredo, V., Vaikath, N., De Risi, M., Paciotti, S., Quiroga-Varela, A., Chiasserini, D., Mellone, M., Mazzocchetti, P., Calabrese, V., Campanelli, F., Mechelli, A., Di Filippo, M., Ghiglieri, V., Picconi, B., Ali El-Agnaf, O., De Leonibus, E., Gardoni, F., Tozzi, A. & 1 others, Calabresi, P., 1 May 2019, In : Brain : a journal of neurology. 142, 5, p. 1365-1385 21 p.

Research output: Contribution to journalArticle

Synucleins
Corpus Striatum
alpha-Synuclein
Parkinson Disease
Long-Term Potentiation
2 Citations (Scopus)

Antibodies against alpha-synuclein: tools and therapies

Vaikath, N., Hmila, I., Gupta, V., Erskine, D., Ingelsson, M. & Ali El-Agnaf, O., 1 Jan 2019, In : Journal of Neurochemistry.

Research output: Contribution to journalReview article

Open Access
alpha-Synuclein
Antibodies
Lewy Bodies
Inclusion Bodies
Pathology

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson's disease

Murakami, H., Tokuda, T., Ali El-Agnaf, O., Ohmichi, T., Miki, A., Ohashi, H., Owan, Y., Saito, Y., Yano, S., Tsukie, T., Ikeuchi, T. & Ono, K., 4 Jun 2019, In : BMC Neurology. 19, 1, 113.

Research output: Contribution to journalArticle

Open Access
Cerebrospinal Fluid Proteins
Parkinson Disease
Cerebrospinal Fluid
Amyloid
Pharmaceutical Preparations
6 Citations (Scopus)

CSF and blood biomarkers for Parkinson's disease

Parnetti, L., Gaetani, L., Eusebi, P., Paciotti, S., Hansson, O., Ali El-Agnaf, O., Mollenhauer, B., Blennow, K. & Calabresi, P., 1 Jun 2019, In : The Lancet Neurology. 18, 6, p. 573-586 14 p.

Research output: Contribution to journalReview article

Synucleins
Parkinson Disease
Biomarkers
Intermediate Filaments
Parkinsonian Disorders

Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

Wu, J. Z., Ardah, M., Haikal, C., Svanbergsson, A., Diepenbroek, M., Vaikath, N., Li, W., Wang, Z. Y., Outeiro, T. F., Ali El-Agnaf, O. & Li, J. Y., 15 Jun 2019, In : Translational Neurodegeneration. 8, 1, 18.

Research output: Contribution to journalArticle

Open Access
Synucleins
alpha-Synuclein
Autophagy
Parkinson Disease
salvianolic acid B